Related Experiment Video

Updated: Aug 6, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Excretion of cyclic 3',5'-adenosine monophosphate in the early newborn period

S R Siegel

    Early Human Development
    |September 1, 1984
    PubMed

    Insights

    Urinary cyclic 3',5'-adenosine monophosphate (cAMP) excretion in newborns is linked to kidney function and gestational age. Higher cAMP levels correlate with better glomerular filtration and longer gestation periods.

    Area of Science:

    • Neonatal physiology
    • Renal function in infants
    • Biochemical markers in newborns

    Background:

    • Cyclic 3",5"-adenosine monophosphate (cAMP) plays a crucial role in cellular signaling.
    • Understanding neonatal renal function is vital for assessing infant health.
    • Establishing baseline biochemical parameters in newborns aids in early detection of potential issues.

    Purpose of the Study:

    • To investigate the relationship between urinary cyclic 3',5'-adenosine monophosphate (cAMP) excretion and key renal function indicators in neonates.
    • To determine if urinary cAMP levels correlate with creatinine clearance, urinary phosphate excretion, or urine osmolarity in early life.
    • To assess the influence of gestational age on urinary cAMP excretion in newborns.

    Main Methods:

    • Studied 29 infants aged 28-40 weeks gestation during the first few days of life.
    • Measured urinary cyclic 3',5'-adenosine monophosphate (cAMP) excretion under basal conditions.
    • Assessed urinary cAMP in relation to creatinine clearance, urinary phosphate excretion, and urine osmolarity.

    Main Results:

    • A direct and significant correlation was found between urinary cAMP excretion and creatinine clearance (r = 0.89, P < 0.001).
    • Urinary cAMP excretion also showed a significant positive relationship with gestational age (r = 0.63, P < 0.001).
    • No significant relationship was observed between urinary cAMP excretion and urinary phosphate excretion or urine osmolarity.

    Conclusions:

    • Urinary cyclic 3',5'-adenosine monophosphate (cAMP) excretion in neonates is primarily dependent on the glomerular filtration rate.
    • Gestational age is a significant factor influencing urinary cAMP excretion levels in newborns.
    • These findings provide insights into the maturation of renal function and cAMP handling in the neonatal period.

    More Related Videos

    HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

    HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

    Published on: July 20, 2016

    Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates05:58

    Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates

    Published on: September 6, 2017

    Related Concept Videos

    Transcytosis of IgG01:15

    Transcytosis of IgG

    Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
    IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
    GPCRs Regulate Adenylyl Cylase Activity01:09

    GPCRs Regulate Adenylyl Cylase Activity

    Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
    Two...
    Drug Excretion: Pulmonary and Glandular Routes01:22

    Drug Excretion: Pulmonary and Glandular Routes

    Gaseous substances like general anesthetics are absorbed and excreted through the lungs via simple diffusion. This process depends on factors such as pulmonary blood flow, respiration rate, and the substance's solubility. Gaseous anesthetics like nitrous oxide with low blood solubility are excreted rapidly, while compounds like alcohol, with high blood and tissue solubility, are excreted slowly.
    Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The process...
    Drug Excretion: Miscellaneous Routes01:10

    Drug Excretion: Miscellaneous Routes

    Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific substances...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...